Home » Stocks » QBIO

Q BioMed Inc. (QBIO)

Stock Price: $1.07 USD 0.00 (0.00%)
Updated December 2, 4:00 PM EST - Market closed

QBIO Stock Price Chart

Key Info

Market Cap 25.05M
Revenue (ttm) 30,000
Net Income (ttm) -13.25M
Shares Out 22.43M
EPS (ttm) -0.65
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day December 2
Last Price $1.07
Previous Close $1.07
Change ($) 0.00
Change (%) 0.00%
Day's Open 1.08
Day's Range 1.07 - 1.10
Day's Volume 18,536
52-Week Range 0.00 - 1.10

QBIO Stock News

There are no news items available yet.

About QBIO

Q BioMed, a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89, a radiopharmaceutical therapeutic for the treatment of bone cancer pain therapies; and Metastron, a radiopharmaceutical drug for metastatic cancer bone pain therapy. It is also developing Man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and U... [Read more...]

Industry
Biotechnology
Founded
2013
Employees
1
Stock Exchange
US OTC
Ticker Symbol
QBIO
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for Q BioMed is 6.00, which is an increase of 460.75% from the latest price.

Price Target
$6.00
(460.75% upside)